JAKi for nonradiographic axSpA One area of continued interest for many rheumatologists is the field of non-radiographic axial spondyloarthritis. And the question of the utility of JAK inhibitors for the treatment of axSpA has been on the rise. https://t.co/xq8ICyKKv0 https://t.co/o2iUgyU60A